Journal of Clinical Medicine Calls for Papers on Breast Cancer Surgery Advances

The Journal of Clinical Medicine is publishing a Special Issue focused on the latest developments in surgical treatment of breast cancer, inviting authors to submit original research and review articles on innovative techniques and advancements by May 14, 2024. The issue aims to explore cutting-edge advancements in surgical treatment, including novel techniques like wire-free localization technology, and share real-world strategies for optimizing breast cancer management. This description highlights the primary topic (surgical treatment of breast cancer), the main entity (Journal of Clinical Medicine), the context (Special Issue and submission deadline), and the significant actions (exploring cutting-edge advancements and sharing real-world strategies). The description also provides objective and relevant details that will help an AI generate an accurate visual representation of the article's content, such as the focus on innovative techniques and real-world strategies.

author-image
Trim Correspondents
New Update
Journal of Clinical Medicine Calls for Papers on Breast Cancer Surgery Advances

Journal of Clinical Medicine Calls for Papers on Breast Cancer Surgery Advances

The Journal of Clinical Medicine has announced a Special Issue focused on the latest developments in surgical treatment of breast cancer. The journal is inviting authors to submit original research and review articles on innovative techniques and advancements in this field by May 14, 2024.

Why this matters: Breast cancer is a significant public health concern, and optimizing treatment strategies is crucial for improving patient outcomes. By sharing the latest findings and insights on surgical treatment, this Special Issue can contribute to refining treatment approaches and addressing the diversity of patient needs.

The Special Issue aims to explore cutting-edge advancements in surgical treatment of breast cancer, including novel techniques and real-world strategies. The journal publishes articles under an open access license, allowing for free reuse and citation of published work. Feature papers, which represent the most advanced research with significant potential for high impact, are submitted upon individual invitation or recommendation by scientific editors.

The surgical treatment of breast cancer has seen significant progress in recent years, particularly with the development of wire-free localization technology such as Magseed. This technology facilitates the localization and retrieval of lymph nodes for staging, enabling targeted axillary dissection (TAD) and de-escalation of axillary surgery. A recent systematic review and pooled analysis published in the Journal of Clinical Medicine evaluated the performance of Magseed in TAD for node-positive patients receiving neoadjuvant systemic therapy. The study found a 100% successful deployment rate, a 94.2% localization rate, a 98.8% retrieval rate, and a 68.8% concordance rate between marked lymph node biopsy and sentinel lymph node biopsy.

Breast cancer is a significant public health concern, and optimizing treatment strategies is crucial for improving patient outcomes. Real-world data and evidence play a vital role in refining treatment approaches and addressing the diversity of patient needs beyond clinical trials. The integration of HER2 testing protocols, patient stratification, and cardiac surveillance is essential for optimizing breast cancer care.

Debu Tripathy, MD, professor and chairman of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, emphasized the importance of reliable HER2 testing in breast cancer management during the 41st Annual Miami Breast Cancer Conference. "Ensuring reliable HER2 testing and seeking guidance from pathologists when needed are crucial steps in breast cancer management," he stated. Tripathy also discussed real-world strategies for CDK4/6 inhibitor use in HER2-positive metastatic breast cancer.

The Special Issue of the Journal of Clinical Medicine presents a valuable opportunity for researchers and clinicians to share their latest findings and insights on surgical treatment of breast cancer. By bringing together original research and review articles on innovative techniques and real-world advancements, this issue aims to further the understanding and optimization of breast cancer management strategies. Authors are encouraged to submit their work by the May 14, 2024 deadline to contribute to this important scientific discourse.

Key Takeaways

  • Journal of Clinical Medicine announces Special Issue on surgical treatment of breast cancer.
  • Deadline for submissions is May 14, 2024, for original research and review articles.
  • Wire-free localization technology, like Magseed, improves breast cancer treatment.
  • Reliable HER2 testing and real-world strategies are crucial for breast cancer management.
  • Special Issue aims to refine treatment approaches and address patient needs.